Final answer:
The duration of DAPT following CABG for stable CAD varies depending on individual patient factors and clinical guidelines. Generally, DAPT is prescribed for 12 months to prevent blood clots and reduce cardiovascular events. However, the optimal duration is still being studied.
Step-by-step explanation:
The duration of dual antiplatelet therapy (DAPT) following coronary artery bypass grafting (CABG) for stable coronary artery disease (CAD) varies depending on individual patient factors and clinical guidelines.
Generally, DAPT, which consists of clopidogrel plus aspirin, is prescribed for a period of 12 months after CABG.
This combination helps to prevent blood clots and reduce the risk of cardiovascular events in patients who have undergone CABG.
However, it's important to note that the optimal duration of DAPT after CABG is still a topic of ongoing research.
Some studies suggest that longer durations of DAPT may have additional benefits in preventing late stent thrombosis, while others recommend shorter durations to minimize bleeding risks.
Ultimately, the decision about the duration of DAPT following CABG for stable CAD should be made on an individual basis, taking into account the patient's specific circumstances and considering the risks and benefits of continued antiplatelet therapy.
The complete question is:
What is the duration of DAPT following CABG for stable CAD?